Cardinal Health, Inc. is a global healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The company provides pharmaceuticals and medical products and cost-effective solutions that enhance supply chain efficiency. Cardinal Health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

Effective January 1, 2024, Cardinal Health operates under an updated organizational structure and realigned its financial reporting structure under two reportable segments: Pharmaceutical and Specialty Solutions ('Pharma') and Global Medical Products and Distribution ('GMPD'). All remaining operating segments that are not significant enough to require separate reportable segment disclosures are included in Other, which is comprised of Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight® Logistics.

• Employees: 48,900 (as of June 30, 2024)
• Geographic Footprint: United States, Canada, Europe, Asia and other markets
• Headquarters: Dublin, Ohio
• Founded: 1979
• Number of locations/facilities: Multiple distribution centers, manufacturing facilities and pharmacies
• Revenue: $226.8 billion (FY2024)
• Key Subsidiaries/Brands: Cardinal Health brand medical products, Red Oak Sourcing, Specialty Networks, Edgepark, Wavemark

• CEO: Jason M. Hollar
• CFO: Aaron E. Alt
• Chief Executive Officer, Pharmaceutical and Specialty Solutions segment: Deborah L. Weitzman
• Chief Executive Officer, GMPD segment: Stephen M. Mason
• Chief Human Resources Officer: Ola M. Snow
• Chief Legal and Compliance Officer: Jessica L. Mayer
• Executive Vice President, Chief Information Officer and Customer Support Services: Michelle D. Greene

The executive experience summaries provided are for positions held during the last five years.

• Annual Revenue: $226.8 billion (FY2024)
• Net Income: $852 million (FY2024)
• Total Assets: $45.1 billion (as of June 30, 2024)
• Employees: 48,900 (as of June 30, 2024)
• Key Financial Highlights: Revenue increased 11 percent in fiscal 2024 compared to fiscal 2023. GAAP operating earnings were $1.2 billion and $752 million during fiscal 2024 and 2023, respectively. GAAP diluted EPS was $3.45 and $1.26 for fiscal 2024 and 2023. Non-GAAP diluted EPS was $7.53 and $5.85 for fiscal 2024 and 2023.

Cardinal Health provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home.

• Pharmaceutical Distribution: Distributes branded and generic pharmaceuticals and over-the-counter healthcare and consumer products. Provides services to pharmaceutical manufacturers, including distribution, inventory management, data reporting, new product launch support and chargeback administration. Provides pharmacy management services to hospitals and operates a limited number of pharmacies, including in community health centers. Repackages generic pharmaceuticals and over-the-counter healthcare products.
• Specialty Solutions: Distributes specialty pharmaceutical products to hospitals, specialty pharmacies, and other healthcare providers. Provides consulting, patient support and other services for specialty pharmaceutical products to pharmaceutical manufacturers and healthcare providers. Provides services to pharmaceutical manufacturers, including distribution, inventory management, data reporting, new product launch support and chargeback administration.
• Global Medical Products and Distribution: Manufactures, sources and distributes Cardinal Health brand medical, surgical and laboratory products. Distributes a broad range of medical, surgical and laboratory products known as national brand products to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. Assembles and sells sterile and non-sterile procedure kits. Provides an automated technology platform for inventory management.
• Nuclear and Precision Health Solutions: Operates nuclear pharmacies and manufacturing facilities, which manufacture, prepare and deliver radiopharmaceuticals for use in nuclear imaging, theranostics, and other procedures in hospitals and physician offices. Contract manufactures a radiopharmaceutical treatment (Xofigo®) and holds the North American rights to manufacture and distribute Lymphoseek®, a radiopharmaceutical diagnostic imaging agent.
• at-Home Solutions: Operates Edgepark, a medical supplies provider that specializes in serving patients with chronic conditions in the home; and at-Home, a business-to-business distribution service that delivers medical supplies and over-the-counter products to home medical equipment providers, home health and hospice agencies, and e-commerce providers.
• OptiFreight® Logistics: Supports the shipping and logistics needs of healthcare providers by optimizing direct shipments through integrated technology solutions.

Cardinal Health operates under two reportable segments:

• Pharmaceutical and Specialty Solutions: Distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. Provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; provides pharmacy management services to hospitals and operates a limited number of pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. This segment's revenue was $210 billion in fiscal 2024.
• Global Medical Products and Distribution: Manufactures, sources and distributes Cardinal Health brand medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a broad range of medical, surgical and laboratory products known as national brand products to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment's revenue was $12.4 billion in fiscal 2024.

Cardinal Health's strategy focuses on providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The company aims to enhance supply chain efficiency and connect various stakeholders for integrated care coordination.

• Strategic Initiatives: The company is focused on expanding its offerings in key therapeutic areas, accelerating upstream data and research opportunities with biopharma manufacturers, and creating a platform for expansion across therapeutic areas. The company is also focused on enterprise-wide cost-savings measures.
• Growth Strategies: Cardinal Health is focused on branded and specialty pharmaceutical sales growth, as well as growth in its generics program. The company is also focused on the growth of Cardinal Health brand medical products.
• Innovation and Future Outlook: The company is investing in technology and data analytics capabilities, including artificial intelligence and modern data analytics.

Cardinal Health operates in the healthcare services and products industry.

• Market Position: Cardinal Health is a major player in the distribution of pharmaceuticals and medical products.
• Key Competitors: Competitors include McKesson Corporation, Cencora, Inc., Medline Industries, Inc., Owens & Minor, Inc. and Becton, Dickinson and Company.
• Industry Trends: The healthcare industry is undergoing significant changes, including a shift towards value-based payments, increased scrutiny of pharmaceutical pricing and supply chains, and consolidation among healthcare providers.

• Legal, Regulatory & Compliance Risks: The company is subject to various legal proceedings, including opioid-related lawsuits and investigations, which could have a negative effect on its results of operations or business. The company is also subject to rigorous regulatory and licensing requirements, and failure to comply could result in penalties.
• Supply Chain and Quality Issues: The company's supply chain and quality issues could adversely affect operations, profitability, cash flows, and financial condition. The company depends on direct and indirect suppliers and is subject to fluctuations in costs, availability and regulatory risks associated with these products and raw materials.
• Cybersecurity Risks: The company's business and results of operations could be adversely affected if it experiences a material cyber-attack or other systems breach.
• Financial Risks: The company could be subject to adverse changes in the tax laws or challenges to its tax positions. Changes to the U.S. healthcare environment may not be favorable to the company.